Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05751733
Status:
RECRUITING
Last Update Posted:
2023-03-02
First Post:
2023-02-08
Brief Title:
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Sponsor:
Xiangya Hospital of Central South University
Organization:
Xiangya Hospital of Central South University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-08
First Submit QC Date:
March 1 2023
Study First Post Date:
2023-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-01
Last Update Post Date:
2023-03-02
Last Update Post Date Type:
ACTUAL